PA
Perceptive Advisors’s Akero Therapeutics AKRO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.9M | Buy |
915,887
+122,927
| +16% | +$6.56M | 1.81% | 15 |
|
|
2025
Q1 | $32.1M | Sell |
792,960
-392,632
| -33% | -$15.9M | 1.13% | 26 |
|
|
2024
Q4 | $33M | Sell |
1,185,592
-529,214
| -31% | -$14.7M | 0.91% | 29 |
|
|
2024
Q3 | $49.2M | Buy |
1,714,806
+214,909
| +14% | +$6.17M | 1.04% | 30 |
|
|
2024
Q2 | $35.2M | Buy |
1,499,897
+112,426
| +8% | +$2.64M | 0.85% | 36 |
|
|
2024
Q1 | $35M | Buy |
1,387,471
+419,696
| +43% | +$10.6M | 0.61% | 50 |
|
|
2023
Q4 | $22.6M | Sell |
967,775
-651,650
| -40% | -$15.2M | 0.5% | 48 |
|
|
2023
Q3 | $81.9M | Sell |
1,619,425
-321,250
| -17% | -$16.2M | 2.73% | 8 |
|
|
2023
Q2 | $90.6M | Buy |
1,940,675
+1,417,150
| +271% | +$66.2M | 2.62% | 11 |
|
|
2023
Q1 | $20M | Buy |
523,525
+173,000
| +49% | +$6.62M | 0.59% | 45 |
|
|
2022
Q4 | $19.2M | Sell |
350,525
-79,475
| -18% | -$4.36M | 0.54% | 43 |
|
|
2022
Q3 | $14.6M | Buy |
+430,000
| New | +$14.6M | 0.42% | 54 |
|
|
2020
Q4 | – | Sell |
-21,938
| Closed | -$675K | – | 138 |
|
|
2020
Q3 | $675K | Buy |
+21,938
| New | +$675K | 0.01% | 118 |
|